Clover Health Investments Corp (CLOV) experienced a significant decline of 5.12% during post-market trading on Thursday. The sharp drop followed the release of the company's latest financial results and forward-looking guidance.

The healthcare company reported mixed quarterly results, with a quarterly adjusted loss of 10 cents per share for the period ended September 30, 2025. While revenue showed strong growth of 47.4% year-over-year to $487.71 million, exceeding analyst expectations, the company reported a substantial quarterly loss of $49.32 million. The earnings performance represented a deterioration compared to the same quarter last year when the company reported a loss of 2 cents per share.

Investors also reacted to the company's full-year 2026 revenue guidance, which projects total revenues between $2.81 billion and $2.92 billion. The market's negative response suggests concerns about the company's continued losses despite revenue growth, as well as potential apprehension about the company's path to profitability.